BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28376210)

  • 1. Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
    Ma R; Karthik GM; Lövrot J; Haglund F; Rosin G; Katchy A; Zhang X; Viberg L; Frisell J; Williams C; Linder S; Fredriksson I; Hartman J
    J Natl Cancer Inst; 2017 Mar; 109(3):1-14. PubMed ID: 28376210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.
    Lillo MA; Nichols C; Perry C; Runke S; Krutilina R; Seagroves TN; Miranda-Carboni GA; Krum SA
    J Appl Toxicol; 2017 Apr; 37(4):417-425. PubMed ID: 27581495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to EGF and 17β‑estradiol irreversibly affects the proliferation and transformation of MCF7 cells but is not sufficient to promote tumor growth in a xenograft mouse model upon withdrawal of exposure.
    Cunha SI; Jia M; Souchelnytskyi S
    Int J Mol Med; 2018 Sep; 42(3):1615-1624. PubMed ID: 29956719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
    Baker R; Dell'Acqua G; Richards A; Thornton MJ
    PLoS One; 2024; 19(2):e0297080. PubMed ID: 38408073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells.
    Treeck O; Schüler-Toprak S; Skrzypczak M; Weber F; Ortmann O
    Steroids; 2020 Jan; 153():108521. PubMed ID: 31604073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype.
    Laranjo M; Carvalho MJ; Costa T; Alves A; Oliveira RC; Casalta-Lopes J; Cordeiro P; Botas F; Abrantes AM; Paiva A; Oliveira C; Botelho MF
    Breast; 2018 Apr; 38():22-29. PubMed ID: 29182983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines.
    Lattrich C; Schüler S; Häring J; Skrzypczak M; Ortmann O; Treeck O
    Arch Gynecol Obstet; 2014 Jan; 289(1):163-71. PubMed ID: 23907354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells.
    Konwisorz A; Springwald A; Haselberger M; Goerse R; Ortmann O; Treeck O
    Endocr Relat Cancer; 2010 Mar; 17(1):147-57. PubMed ID: 19942713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.
    Christensen AG; Ehmsen S; Terp MG; Batra R; Alcaraz N; Baumbach J; Noer JB; Moreira J; Leth-Larsen R; Larsen MR; Ditzel HJ
    Stem Cells; 2017 Aug; 35(8):1898-1912. PubMed ID: 28600813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.